BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10817485)

  • 1. Testing an individualized digital decision assist system for the diagnosis and management of mental and behavior disorders in children and adolescents.
    Clausen CE; Leventhal BL; Nytrø Ø; Koposov R; Westbye OS; Røst TB; Bakken V; Koochakpour K; Thorvik K; Skokauskas N
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):232. PubMed ID: 32943029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate.
    Wanchoo SJ; Swann AC; Dafny N
    Brain Res; 2009 Dec; 1301():68-79. PubMed ID: 19747456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-existing symptoms and risk factors among African school children with hyperactivity-inattention symptoms in Kinshasa, Congo.
    Kashala E; Lundervold A; Sommerfelt K; Tylleskär T; Elgen I
    Eur Child Adolesc Psychiatry; 2006 Aug; 15(5):292-9. PubMed ID: 16583124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit and hyperactivity disorder among school children in Kinshasa, Democratic Republic of Congo.
    Kashala E; Tylleskar T; Elgen I; Kayembe KT; Sommerfelt K
    Afr Health Sci; 2005 Sep; 5(3):172-81. PubMed ID: 16245986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2002 Oct; 22(19):8705-10. PubMed ID: 12351745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
    Vaughan BS; Wetzel MW; Kratochvil CJ
    Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset.
    Zuddas A; Ancilletta B; Muglia P; Cianchetti C
    Eur J Paediatr Neurol; 2000; 4(2):53-62. PubMed ID: 10817485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit hyperactivity disorder in preschool children.
    Greenhill LL; Posner K; Vaughan BS; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):347-66, ix. PubMed ID: 18295150
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.